Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | 4-Nitrophenol | HCID 980 | — |
| Edukt | Phenol | HCID 996 | — |
| Edukt | 2,4-Dinitrophenol | HCID 1493 | — |
| Edukt | 2-Nitrophenol | HCID 6947 | — |
| Edukt | Phosphorus | HCID 5462309 | — |
| Produkt | HCID 178515957 | HCID 178515957 | — |
Reaktionsschritte
The phosphorous chloridate Compound 100c reacts with an activated phenol such as 4-nitrophenol, 2-nitrophenol, and 2,4-dinitrophenol, in the presence of a suitable base to give a phosphorous phenolate Compound 100d that is stable for further purification. Compound 100d is then coupled with a Nucleoside; a solution of a Nucleoside in NMP (˜30 mL/mmol) is cooled to 0° C. using an ice bath. To this mixture, a solution of t-BuMgCl in THF (1.0 M, 1.5-2.5 eq. to the nucleoside) is added dropwise. A solution of Compound 100d (˜1.5 eq. to the nucleoside) in THF (˜15 mL/mmol) is then added dropwise to the reaction mixture. The resulting mixture is allowed to warm up to room temperature and stirred for 16 h. The solution is then quenched with H2O (˜30 mL/mmol) and purified via reverse phase HPLC (30-60% CH3CN in H2O). The product fractions are combined, concentrated under vacuum, and then further purified using flash silica gel chromatography (1-35% MeOH in CH2Cl2) to give a monophosphate prodrug Compound PD-A. The diasteromeric mixture of Compound 100d is optionally separated into two single stereoisomers Compound (S)-100d and Compound (R)-100d by crystallization or chromatography prior to coupling with the Nucleoside to afford a single stereoisomer Compound (S)-PD-A or Compound (R)-PD-A.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US08877733B2 |
|---|
| Quelldatensatz | uspto-grants-2014_11 |
|---|
| ORD ID | ord-1e97bdd6e2d84f58b9af90d2846b4f11 |
|---|
| Quellennotiz | uspto-grants-2014_11 |
|---|